Business Investment Opportunities - Invest in a Business

4000+ Business Investment Opportunities as on December 2018. Invest in a Business from 148 countries, 950+ Industries, with profit margins up to 60%. Explore pre-screened Business Investment Opportunities with verified contact details, valuation details and business photographs. Join our 613,000+ member network to Invest in a Business. Create a Business profile to Finance your Business.

Filters
  • Investment Opportunities

Bio Therapeutic Drugs Company Investment Opportunity in Gurgaon, India

Cancer immunotherapy based research & medicine manufacturing company based out of Gurgaon.
- Business came into existence in the year 2010 with a vision to find the roots of cancer and to improve the quality of life by immunology based Dendritic cell-based therapy. - Company aims to provide an economical and effective method of DC immunotherapy in India. - We received the Indian FDA approval to manufacture / market immunotherapy treatment-related medicines for cancer in India in Dec 2017. We started selling medicines from April 2018. - Tie-ups with various hospitals, oncologists and Government health schemes for the supply of products in Delhi NCR region. - We prepare custom-made medicine for each & every patient. So the production number depends upon the requirements from customers. - Company launched Phase II clinical trials across 7 hospitals in India where it treated 51 patients. - We have the capacity to treat 600 patients on an annual basis. The company was conferred with the Excellence award for DC clinical trial at UAE Cancer Congress at Dubai. - Company would start making profits in the near future. Last our sales was only from the research work. This year sale of medicines too helped in revenue generation. We will continue to see this improving. - Promoter1: A visionary entrepreneur, responsible for developing dendritic cell immunotherapy at a commercial scale in India. - Promoter2: A first generation entrepreneur responsible for bringing the cellular therapies in India.
8.4   Gurgaon
Run Rate Sales
USD 250 thousand
EBITDA Margin
Undisclosed
Financial Investment
USD 17 million for 26% stake
Contact Business

Profitable Surveillance Devices Company Investment Opportunity in New York, United States

Company is a recognized pioneer, leader and first mover in the security technology market.
The Company’s product portfolio includes its unique flagship security product that is patented and recognized as superior by Public and Private Customers. Product Vendor of Record for DHS – The Company is a Government Services Administration ( GSA ) authorized Small Business Vendor and is the Product Vendor of Record on the U. S. Department of Homeland Security Approved Equipment List ( AEL. Company has sold thousands of units and generated millions in revenue despite highly constrained financial and human resources; demonstrating a proven need for the Company’s products in the marketplace. Interest and inquiries into the Company and its products continue to increase. The Company also has developed strategic relationships with key government entities and completed a number of projects for large blue-chip clients in the private sector. The Company currently has profit margins in excess of 65. The opportunity for further efficiency exists with a manufacturing partner, and recurring revenue streams are opened with a service-oriented partner. The Company’s target marketplace includes tens of millions of unprotected access points throughout the United States alone, representing a market opportunity exceeding $20B, which remains untapped. The Company has proprietary technology and strategic political relationships that are critical for maintaining a dominant position in this market.
8.0   New York
Run Rate Sales
USD 3 million
EBITDA Margin
60 %
Financial Investment
USD 15 million for 50% stake
Contact Business
Need help?